Trials / Conditions / Gynecologic Neoplasms

Gynecologic Neoplasms

11 registered clinical trials studyying Gynecologic Neoplasms.

Status	Trial	Sponsor	Phase
Completed	Impact of Preoperative Sleep Quality and Anxiety on Postoperative Outcomes in Abdominal Gynecologic Cancer Sur NCT07036549	Izmir City Hospital	—
Active Not Recruiting	Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colo NCT05185947	National Cancer Institute (NCI)	Phase 2
Terminated	PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platin NCT04493619	Opna Bio LLC	Phase 1 / Phase 2
Completed	A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple NCT03101280	Hoffmann-La Roche	Phase 1
Completed	Emerging From the Haze for Gynecologic Cancer Survivors NCT02918461	Cedars-Sinai Medical Center	N/A
Completed	A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers NCT02728830	AA Secord	EARLY_Phase 1
Completed	Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy NCT02786524	University of Michigan	N/A
Completed	Thromboprophylaxis After Surgery for Gynecologic Malignancy in China NCT02935530	Huazhong University of Science and Technology	Phase 3
Completed	Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy NCT02653469	Samsung Medical Center	—
Completed	Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients NCT02309944	Masonic Cancer Center, University of Minnesota	N/A
Withdrawn	Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer NCT00328757	Chiang Mai University	Phase 3